Polar Capital Holdings Plc

Position in ASND — Ascendis Pharma A/S

CIK 1837309 London, X0

Position in ASND

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$164,541,701

+$15,475,616 QoQ

Shares Held

616,908

-5.3% QoQ

Ownership

0.941%

of shares outstanding

% of Portfolio

0.47%

of 13F equity value

Holder Rank

#18

of 308 holders

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Polar Capital Holdings Plc holds $3,774,805,029 across 41 Biotechnology names. ASND ranks #6 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELVN	Enliven Therapeutics, Inc.	6,430,636	$326,354,777
2	XENE	Xenon Pharmaceuticals Inc.	4,570,556	$275,878,760
3	CYTK	Cytokinetics Inc	2,253,649	$191,988,358
4	RYTM	Rhythm Pharmaceuticals, Inc.	1,663,632	$184,713,060
5	ARQT	Arcutis Biotherapeutics, Inc.	6,606,945	$173,234,097
6	ASND	Ascendis Pharma A/S This page	616,908	$164,541,701
7	BBIO	BridgeBio Pharma, Inc.	2,063,609	$153,697,598
8	ALNY	Alnylam Pharmaceuticals, Inc.	482,751	$145,322,533

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$164,541,701	616,908	-5.3%	Shares	Defined	2026-08-14
2026-03-31	$149,066,085	651,712	+75.9%	Shares	Defined	2026-05-15
2025-12-31	$78,999,662	370,473	-56.8%	Shares	Defined	2026-02-17
2025-09-30	$170,561,285	857,911	+2.4%	Shares	Defined	2025-11-14
2025-06-30	$144,600,310	837,777	+59.6%	Shares	Defined	2025-08-14
2025-03-31	$81,826,500	525,000	+75.0%	Shares	Defined	2025-05-15
2024-12-31	$41,301,000	300,000	+33.3%	Shares	Defined	2025-02-14
2024-09-30	$33,594,750	225,000	+8814.4%	Shares	Defined	2024-11-14
2021-03-31	$325,293	2,524	-95.2%	Shares	Sole	2021-05-17
2020-12-31	$8,759,952	52,524	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.